Literature DB >> 6979801

Precipitating antibody to a soluble nuclear antigen "Ki" with specificity for systemic lupus erythematosus.

T Tojo, J Kaburaki, M Hayakawa, T Okamoto, M Tomii, M Homma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6979801

Source DB:  PubMed          Journal:  Ryumachi        ISSN： 0300-9157


× No keyword cloud information.
  8 in total

1.  Characterisation of centromere (kinetochore) antigen reactive with sera of patients with a scleroderma variant (CREST syndrome).

Authors:  M Nishikai; Y Okano; H Yamashita; M Watanabe
Journal:  Ann Rheum Dis       Date:  1984-12       Impact factor: 19.103

Review 2.  Significance of Autoantibodies to Ki/SL as Biomarkers for Systemic Lupus Erythematosus and Sicca Syndrome.

Authors:  Michael Mahler; Chelsea Bentow; Mary-Ann Aure; Marvin J Fritzler; Minoru Satoh
Journal:  J Clin Med       Date:  2022-06-20       Impact factor: 4.964

3.  The SL autoantibody-antigen system: clinical and biochemical studies.

Authors:  R M Bernstein; S H Morgan; C C Bunn; R C Gainey; G R Hughes; M B Mathews
Journal:  Ann Rheum Dis       Date:  1986-05       Impact factor: 19.103

4.  MEKK3 interacts with the PA28 gamma regulatory subunit of the proteasome.

Authors:  Carsten Hagemann; Rajnikant Patel; Jonathan L Blank
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

5.  Cloning and nucleotide sequence of cDNA for Ki antigen, a highly conserved nuclear protein detected with sera from patients with systemic lupus erythematosus.

Authors:  T Nikaido; K Shimada; M Shibata; M Hata; M Sakamoto; Y Takasaki; C Sato; T Takahashi; Y Nishida
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

6.  Autoantibodies against the replication protein A complex in systemic lupus erythematosus and other autoimmune diseases.

Authors:  Yoshioki Yamasaki; Sonali Narain; Liza Hernandez; Tolga Barker; Keigo Ikeda; Mark S Segal; Hanno B Richards; Edward K L Chan; Westley H Reeves; Minoru Satoh
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

Review 7.  PA28γ: New Insights on an Ancient Proteasome Activator.

Authors:  Paolo Cascio
Journal:  Biomolecules       Date:  2021-02-05

8.  Increased proteasome activator 28 gamma (PA28γ) levels are unspecific but correlate with disease activity in rheumatoid arthritis.

Authors:  Melanie Gruner; Anja Moncsek; Stefan Rödiger; Dagmar Kühnhardt; Eugen Feist; Ralf Stohwasser
Journal:  BMC Musculoskelet Disord       Date:  2014-12-08       Impact factor: 2.362
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.